Autolus Therapeutics plc filed a Form S-8 registration statement with the U.S. Securities and Exchange Commission on November 13, 2026, to register an additional 10,653,613 ordinary shares represented by American Depositary Shares under its 2018 Equity Incentive Plan.
Rail Vision Ltd. filed a Form S-8 registration statement with the U.S. Securities and Exchange Commission on November 13, 2026, to register an additional 300,000 ordinary shares issuable under its Amended Share Option Plan.
Lyell Immunopharma, Inc. filed a Form S-3 registration statement with the SEC on November 13, 2026, covering the resale of up to 7,428,040 shares of common stock by selling stockholders who received those shares in a private placement that closed on November 4, 2026.
SHF Holdings, Inc. filed a current report on Form 8-K on November 13, 2026, disclosing a Nasdaq delisting determination, a waiver extending its registration statement filing deadline, and the issuance of more than 63 million shares of common stock through Series B Preferred Stock …
Lindsay Corporation filed a preliminary proxy statement on November 13, 2026, ahead of its Fiscal 2027 Annual Meeting of Stockholders scheduled for January 5, 2027, outlining five proposals including a board declassification amendment and director elections.
Unusual Machines, Inc. filed a Form S-3 registration statement with the SEC on November 13, 2026, covering the resale of up to 1,929,272 shares of common stock by selling stockholders connected to two separate acquisition transactions.
Westwater Resources, Inc. filed a Form S-1 registration statement with the SEC on November 13, 2026, covering the resale of up to 26,141,858 shares of common stock by selling stockholder Lincoln Park Capital Fund, LLC under a purchase agreement dated November 10, 2026.
BranchOut Food Inc. filed a Definitive Proxy Statement on November 13, 2026, inviting stockholders to its 2026 Annual Meeting scheduled for December 30, 2026 at 9:30 a.m. Pacific Standard Time at the company's principal offices in Bend, Oregon.
CNO Financial Group, Inc. filed a Form 8-K on November 13, 2026, disclosing that it entered into a Sixth Amended and Restated Section 382 Rights Agreement on that same date, extending its shareholder rights plan through November 13, 2029.
Elicio Therapeutics, Inc. filed a Form 8-K on November 13, 2026, reporting the final voting results from its 2026 annual meeting of stockholders held on November 12, 2026.